TrialOncotarget2016

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer.

Andrea L A Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.